most common glp-1 trends 2025: real-world data, patient outcomes & future therapies A monthly GLP-1 dose could

So you're taking in more calories and you're burning a little more calories off, but it's because you are actually bigger

Sushovan Guha, MD, MA, PhD, FASGE, AGAF, is a Houston-based gastroenterologist and hepatologist at Houston Regional Gastroenterology Institute with extensive academic experience, specializing in general GI care, colorectal cancer prevention, and advanced endoscopic procedures.

Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

This treatment results in lowered TNF- [8] and IL-17 levels [8], blocks NF-B signaling pathways [8,55], and decreases both C-reactive protein [19] and IL-6 levels [19]

As long as youre injecting into subcutaneous fat, everything should be fine

[DOI] [PubMed] [Google Scholar] 53.Deacon C.F., Holst J.J